{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:12:03Z","timestamp":1773202323105,"version":"3.50.1"},"reference-count":16,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NDT"],"DOI":"10.2147\/ndt.s343840","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T15:20:21Z","timestamp":1639408821000},"page":"3655-3661","source":"Crossref","is-referenced-by-count":10,"title":["Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched Study"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Haruna","family":"Matsuzaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-878X","authenticated-orcid":true,"given":"Masakazu","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miko","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","volume":"56","author":"Robinson","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.jpsychires.2012.05.001","volume":"46","author":"Caseiro","year":"2012","journal-title":"J Psychiatr Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1007\/s00213-016-4295-9","volume":"233","author":"Kinoshita","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/0706743716661324","volume":"62","author":"Orr","year":"2017","journal-title":"Can J Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1517\/17425255.2014.908185","volume":"10","author":"Citrome","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4088\/JCP.12m08271","volume":"75","author":"Kemp","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4103\/0976-500X.64538","volume":"1","author":"Balaraman","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"ref9","first-page":"60","volume":"50","author":"Zhou","year":"2020","journal-title":"Psychopharmacol Bull"},{"key":"ref10","first-page":"1495","volume":"21","author":"Kamei","year":"2018","journal-title":"Jpn J Clin Psychopharmacol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/pcn.12275","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1517\/14740338.2014.908183","volume":"13","author":"Citrome","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40261-017-0592-2","volume":"38","author":"Vieta","year":"2018","journal-title":"Clin Drug Investig"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/bdd.718","volume":"31","author":"Gerrits","year":"2010","journal-title":"Biopharm Drug Dispos"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.9758\/cpn.2021.19.4.610","volume":"19","author":"Hatano","year":"2021","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd013521","volume":"2020","author":"Quinn","year":"2020","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Neuropsychiatric Disease and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=76702","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=76702","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T15:20:25Z","timestamp":1639408825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/treatment-continuation-of-asenapine-or-olanzapine-in-japanese-schizoph-peer-reviewed-fulltext-article-NDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":16,"URL":"https:\/\/doi.org\/10.2147\/ndt.s343840","relation":{},"ISSN":["1178-2021"],"issn-type":[{"value":"1178-2021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}